Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myo-inositol Versus Clomiphene Citrate as First Line Treatment for Ovulation Induction in PCOS

NCT04306692 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT04306692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myo-inositol Versus Clomiphene Citrate as First Line Treatment for Ovulation Induction in PCOS
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Terminated
Start date
July 2, 2020
Completion date
January 31, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clomiphene, inositol, ovulation induction, polycystic ovary syndrome